2024
Integration of observational and causal evidence for the association between adiposity and 17 gastrointestinal outcomes: An umbrella review and meta‐analysis
Kim M, Lee I, Natarajan P, Do R, Kwon Y, Shin J, Solmi M, Kim J, Won H, Park S. Integration of observational and causal evidence for the association between adiposity and 17 gastrointestinal outcomes: An umbrella review and meta‐analysis. Obesity Reviews 2024, 25: e13823. PMID: 39233338, DOI: 10.1111/obr.13823.Peer-Reviewed Original ResearchConceptsBody mass indexMendelian randomizationPublic health policiesUmbrella reviewStandard deviation increaseUpper GI conditionsGI diseasesHealth policyEpidemiological researchGI conditionsSystematic reviewMass indexMeta-analysesObservational studyDeviation increaseIncreased riskMeta-analysisObesityGastrointestinal outcomesGastrointestinal (GI) diseasesIncreased AdiposityAssociationRectal cancerGallbladder diseaseFatty liver disease
2013
Comparison of open and endovascular treatment of acute mesenteric ischemia
Beaulieu R, Arnaoutakis K, Abularrage C, Efron D, Schneider E, Black J. Comparison of open and endovascular treatment of acute mesenteric ischemia. Journal Of Vascular Surgery 2013, 59: 159-164. PMID: 24199769, DOI: 10.1016/j.jvs.2013.06.084.Peer-Reviewed Original ResearchMeSH KeywordsAgedChi-Square DistributionDigestive System Surgical ProceduresEndovascular ProceduresFemaleHospital MortalityHumansIschemiaLength of StayMaleMesenteric IschemiaParenteral Nutrition, TotalRisk FactorsTime FactorsTreatment OutcomeUnited StatesVascular DiseasesVascular Surgical ProceduresConceptsAcute mesenteric ischemiaBowel resectionLength of stayEndovascular repairOpen revascularizationEndovascular treatmentEndovascular interventionMesenteric ischemiaParenteral nutritionVascular repairVascular interventionsDiagnosis of AMINational Inpatient Sample databaseSubsequent vascular interventionProportion of patientsSeverity of comorbiditiesTotal parenteral nutritionNinth Revision codesPatient-level dataStudy time periodCharlson indexTPN supportSame hospitalizationBowel perfusionGastrointestinal outcomes
2007
Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison
Laine L, Curtis SP, Cryer B, Kaur A, Cannon CP, Committee F. Assessment of upper gastrointestinal safety of etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison. The Lancet 2007, 369: 465-473. PMID: 17292766, DOI: 10.1016/s0140-6736(07)60234-7.Peer-Reviewed Original ResearchMeSH KeywordsAgedAnti-Inflammatory Agents, Non-SteroidalArthritisArthritis, RheumatoidAspirinCyclooxygenase 2 InhibitorsCyclooxygenase InhibitorsDiclofenacEtoricoxibFemaleGastrointestinal DiseasesGastrointestinal HemorrhageHumansMaleMiddle AgedOsteoarthritisPeptic UlcerPlatelet Aggregation InhibitorsProton Pump InhibitorsPyridinesSulfonesConceptsProton pump inhibitorsNon-steroidal anti-inflammatory drugsUpper gastrointestinal safetyLow-dose aspirinClinical eventsGastrointestinal safetyRheumatoid arthritisUncomplicated eventsTraditional non-steroidal anti-inflammatory drugsConcomitant proton pump inhibitorsLow-dose aspirin useCOX-2 selective inhibitorsTraditional NSAID diclofenacAnti-inflammatory drugsStandard clinical practiceSelective inhibitorGastrointestinal eventsMultinational EtoricoxibAspirin useGastrointestinal outcomesTreat analysisProtective therapyPump inhibitorsCyclo-oxygenaseNSAID diclofenac
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply